UroGen Pharma Ltd. - Ordinary Shares — Quarterly Financial Statistics (NASDAQ:URGN) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -13.62 M-42.02 M-39.83 M-42.27 M-38.33 M-45.32 M -165.74 M Cash from investing activities 60.62 M-25.96 M28.41 M31.4 M27.72 M-20.69 M 66.83 M Cash from financing activities 71 K34 K296 K8.27 M31.32 M65.2 M 105.09 M Free cash flow -13.62 M-42.02 M-39.97 M-42.36 M-38.34 M-45.37 M -166.03 M

News

IBRX and the BCG Shortage: Deals That Could Expand Demand

UroGen Pharma Ltd. (URGN) Discusses Real-World Experiences and Outcomes With ZUSDURI for Recurrent Bladder Cancer Transcript

Urogen Pharma (URGN) Just Flashed Golden Cross Signal: Do You Buy?

Urogen Pharma (URGN) Reports Q1 Loss, Beats Revenue Estimates

Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Beats Revenue Estimates

IBRX: What Anktiva's Bladder Data Says About 2026 Sales

UroGen: ZUSDURI Poised To Replace TURBT Surgery As SOC In Certain Bladder Cancers

UroGen Pharma at TD Cowen Conference: Strategic Growth and Innovation

Oppenheimer raises UroGen Pharma stock price target to $34 on Zusduri sales

Oppenheimer reiterates UroGen Pharma stock rating on strong Zusduri sales

Earnings call transcript: UroGen Pharma Q4 2025 misses EPS and revenue forecasts

Palantir and AeroVironment among market cap stock movers on Monday